<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
      <journal-id journal-id-type="publisher-id">J CLIN INVEST</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Clinical Investigation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0021-9738</issn>
      <issn pub-type="epub">1558-8238</issn>
      <publisher>
        <publisher-name>American Society for Clinical Investigation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25105364</article-id>
      <article-id pub-id-type="pmc">4151221</article-id>
      <article-id pub-id-type="publisher-id">73264</article-id>
      <article-id pub-id-type="doi">10.1172/JCI73264</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hypomorphism in human <italic>NSMCE2</italic> linked to primordial dwarfism and insulin resistance</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Payne</surname>
            <given-names>Felicity</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Colnaghi</surname>
            <given-names>Rita</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rocha</surname>
            <given-names>Nuno</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Seth</surname>
            <given-names>Asha</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harris</surname>
            <given-names>Julie</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carpenter</surname>
            <given-names>Gillian</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bottomley</surname>
            <given-names>William E.</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wheeler</surname>
            <given-names>Eleanor</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>Stephen</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saudek</surname>
            <given-names>Vladimir</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Savage</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O&#x2019;Rahilly</surname>
            <given-names>Stephen</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carel</surname>
            <given-names>Jean-Claude</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">6</xref>
          <xref ref-type="aff" rid="JCI73264">7</xref>
          <xref ref-type="aff" rid="JCI73264">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barroso</surname>
            <given-names>In&#xEA;s</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">1</xref>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>O&#x2019;Driscoll</surname>
            <given-names>Mark</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Semple</surname>
            <given-names>Robert</given-names>
          </name>
          <xref ref-type="aff" rid="JCI73264">3</xref>
          <xref ref-type="aff" rid="JCI73264">4</xref>
        </contrib>
      </contrib-group>
      <aff id="JCI73264"><label>1</label>The Wellcome Trust Sanger Institute, Cambridge, United Kingdom. <label>2</label>Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton, United Kingdom. <label>3</label>The University of Cambridge Metabolic Research Laboratories, Wellcome Trust&#x2013;MRC Institute of Metabolic Science, Cambridge, United Kingdom. <label>4</label>The National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, United Kingdom. <label>5</label>Department of Endocrinology and Diabetes, Glan Clwyd Hospital, North Wales, United Kingdom. <label>6</label>University Paris Diderot, Paris, France. <label>7</label>Assistance Publique-H&#xF4;pitaux de Paris (AP-HP), H&#xF4;pital Robert Debr&#xE9;, Department of Pediatric Endocrinology and Diabetology, and Centre de R&#xE9;f&#xE9;rence des Maladies Endocriniennes Rares de la Croissance, Paris, France. <label>8</label>Institut National de la Sant&#xE9; et de la Recherche M&#xE9;dicale Unit&#xE9; CIE-5, Paris, France.</aff>
      <author-notes>
        <corresp>Address correspondence to: Robert K. Semple, University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Box 289, Addenbrooke&#x2019;s Hospital, Cambridge CB2 0QQ, United Kingdom. Phone: 44.1223.769.035; E-mail: <email>rks16@cam.ac.uk</email>. Or to: In&#xEA;s Barroso, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, CB10 1SA, United Kingdom. Phone: 44.0.1223.496.928; E-mail: <email>ib1@sanger.ac.uk</email>. Or to: Mark O&#x2019;Driscoll, Human DNA Damage Response Disorders Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RQ, United Kingdom. Phone: 44.0.1273.877.515; E-mail: <email>m.o-driscoll@sussex.ac.uk</email>. Or to: Jean-Claude Carel, Universit&#xE9; Paris Diderot, Sorbonne Paris Cit&#xE9; &amp; INSERM CIE-5, Pr&#xE9;sident CMEL H&#xF4;pital Universitaire Robert-Debr&#xE9;, 48, boulevard S&#xE9;rurier, 75935 Paris cedex 19, France. Phone: 33.1.40.03.41.05; E-mail: <email>jean-claude.carel@inserm.fr</email>.</corresp>
        <fn>
          <p><bold>Authorship note:</bold> Felicity Payne, Rita Colnaghi, Nuno Rocha, and Asha Seth contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <day>2</day>
        <month>9</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
      <volume>124</volume>
      <issue>9</issue>
      <fpage>4028</fpage>
      <lpage>4038</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>6</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2014, American Society for Clinical Investigation</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>American Society for Clinical Investigation</copyright-holder>
      </permissions>
      <abstract>
        <p>Structural maintenance of chromosomes (SMC) complexes are essential for maintaining chromatin structure and regulating gene expression. Two the three known SMC complexes, cohesin and condensin, are important for sister chromatid cohesion and condensation, respectively; however, the function of the third complex, SMC5&#x2013;6, which includes the E3 SUMO-ligase NSMCE2 (also widely known as MMS21) is less clear. Here, we characterized 2 patients with primordial dwarfism, extreme insulin resistance, and gonadal failure and identified compound heterozygous frameshift mutations in <italic>NSMCE2</italic>. Both mutations reduced NSMCE2 expression in patient cells. Primary cells from one patient showed increased micronucleus and nucleoplasmic bridge formation, delayed recovery of DNA synthesis, and reduced formation of foci containing Bloom syndrome helicase (BLM) after hydroxyurea-induced replication fork stalling. These nuclear abnormalities in patient dermal fibroblast were restored by expression of WT NSMCE2, but not a mutant form lacking SUMO-ligase activity. Furthermore, in zebrafish, knockdown of the NSMCE2 ortholog produced dwarfism, which was ameliorated by reexpression of WT, but not SUMO-ligase&#x2013;deficient NSMCE. Collectively, these findings support a role for NSMCE2 in recovery from DNA damage and raise the possibility that loss of its function produces dwarfism through reduced tolerance of replicative stress.</p>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>